These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8219714)

  • 41. Expression of hepatocyte and oval cell antigens in hepatocellular carcinomas produced by oncogene-transfected liver epithelial cells.
    Goyette M; Faris R; Braun L; Hixson D; Fausto N
    Cancer Res; 1990 Aug; 50(15):4809-17. PubMed ID: 2196118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The experimental study on the oval cells participating in hepatocarcinogenesis].
    Gong JQ; Fang CH; Li Y; Tian FZ
    Zhonghua Wai Ke Za Zhi; 2004 Mar; 42(5):291-5. PubMed ID: 15062020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distribution of oval cells and c-myc mRNA expression in mouse hepatocarcinogenesis.
    Fang CH; Zhang GQ; Zhu XY; Gong JQ
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):433-9. PubMed ID: 15313684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular and molecular changes in the early stages of chemical hepatocarcinogenesis in the rat.
    Evarts RP; Nakatsukasa H; Marsden ER; Hsia CC; Dunsford HA; Thorgeirsson SS
    Cancer Res; 1990 Jun; 50(11):3439-44. PubMed ID: 1692260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular origin of regenerating parenchyma in a mouse model of severe hepatic injury.
    Braun KM; Sandgren EP
    Am J Pathol; 2000 Aug; 157(2):561-9. PubMed ID: 10934158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of matrix metalloproteinase-2 and -9 and of tissue inhibitor of matrix metalloproteinase-1 in liver regeneration from oval cells in rat.
    Pham Van T; Couchie D; Martin-Garcia N; Laperche Y; Zafrani ES; Mavier P
    Matrix Biol; 2008 Oct; 27(8):674-81. PubMed ID: 18678246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A model of hepatic regeneration and carcinogenesis due to total liver cell injury induced by dipin and partial hepatectomy.
    Uryvaeva IV
    Monogr Dev Biol; 1992; 23():230-6. PubMed ID: 1614438
    [No Abstract]   [Full Text] [Related]  

  • 48. Generation of hepatocytes from oval cell precursors in culture.
    Lázaro CA; Rhim JA; Yamada Y; Fausto N
    Cancer Res; 1998 Dec; 58(23):5514-22. PubMed ID: 9850088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Formation of aberrant polyploid hepatocytes in exposure to the alkylating preparation dipin and to stimulation of proliferation].
    Uryvaeva IV; Faktor VM
    Tsitologiia; 1982 Aug; 24(8):911-7. PubMed ID: 7135484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma.
    Brooling JT; Campbell JS; Mitchell C; Yeoh GC; Fausto N
    Hepatology; 2005 Apr; 41(4):906-15. PubMed ID: 15799032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo cell lineage analysis during chemical hepatocarcinogenesis using retroviral-mediated gene transfer.
    Bralet MP; Calise D; Brechot C; Ferry N
    Lab Invest; 1996 May; 74(5):871-81. PubMed ID: 8642783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo.
    Li CH; Wang YJ; Dong W; Xiang S; Liang HF; Wang HY; Dong HH; Chen L; Chen XP
    Cancer Lett; 2011 Dec; 311(1):1-10. PubMed ID: 21821357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histopathology of IQ-induced hepatocarcinogenesis in nonhuman primates.
    Thorgeirsson UP; Gomez DE; Nagy P; Sinha CC; Adamson RH
    Princess Takamatsu Symp; 1995; 23():274-80. PubMed ID: 8844819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell specificity of rat cytokeratin p39 during azo dye-induced hepatocarcinogenesis.
    Schmidt WN; Page DL; McKusick K; Hnilica LS
    Carcinogenesis; 1985 Aug; 6(8):1147-53. PubMed ID: 2410160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transplantable mouse hepatoblastoma: histologic, ultrastructural and immunohistochemical study.
    Kharkovskaya NA; Svinolupova SI; Khrustalev SA; Engelhardt NV; Kondalenko VF; Poltoranina VS; Turusov VS
    Exp Pathol; 1990; 40(4):283-9. PubMed ID: 1711480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?
    Sell S
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):15-26. PubMed ID: 7516873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Possibility of transitioning highly-differentiated Sertoli cells to proliferation after exposure to chemical mutagens].
    Zakhidov ST; Marshak TL; Golichenkov VA
    Dokl Akad Nauk; 1995 Oct; 344(5):692-4. PubMed ID: 8563647
    [No Abstract]   [Full Text] [Related]  

  • 58. [The assessment of the level of genetic damages accumulated with age and induced in liver cells by the micronucleus production].
    Uryvaeva IN; Delone GV
    Ontogenez; 1992; 23(4):370-8. PubMed ID: 1454292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrastructural study of hepatocellular carcinoma induced by hexachlorocyclohexane.
    Kandarkar SV; Munir KM; Bhide SV; Sirsat SM
    Indian J Med Res; 1983 Jul; 78 Suppl():155-61. PubMed ID: 6197372
    [No Abstract]   [Full Text] [Related]  

  • 60. Ultrastructural cytochemistry of eosinophilic inclusions in the cells of hyperplastic nodules and hepatomas in mouse liver.
    Muzzillo DA; Hoshino M; Matsuyama M
    Acta Pathol Jpn; 1991 Nov; 41(11):806-10. PubMed ID: 1723838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.